Advertisement

Topics

Search Results for "India Anty Sex"

23:46 EDT 28th May 2016 | BioPortfolio

Matching Channels

India ink colloidal carbon stain

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

Matching News

Regulation and uptake of ‘similar biologics’ in India

India has, by far, demonstrated the greatest acceptance of ‘similar biologics’. But what are the drivers and the limitations to the ‘similar biologics’ market in India? This is a question Dr N...

Low costs and less stringent regulatory requirements in India

Dr Nagaraj Malipatil, a clinical pharmacologist, from Bangalore, India in his review of ‘similar biologics’ in India, outlines some of the drivers of the ‘similar biologics’ market in India [1...

Syncom Formulations (India) Ltd (524470) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Syncom Formulations (India) Ltd (524470) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This ...

Interview: Revolution At GSK India

Brace for GSK India's new avatar. The British multinational is revamping its business model in India and donning a new approach to create, deliver and capture value via a "one team" effort as it striv...

Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. Th...

Strengthening our Regulatory Relationships in India

By: Mathew T. Thomas and Dean Rugnetta India’s economic expansion is in part due to the tremendous growth in the pharmaceutical industry. The United States is a large consumer of medical products, a...

After GoI Debacle, Is It Any Easier To Perform Clinical Trials In India?

In May 2014, I interviewed Mithra Bindhu of India-based Asiatic Clinical Research to get an update on performing clinical trials in that country. The DCGI (Drug Controller General of India) had recent...

INTERVIEW: A Revolution At GSK India

Brace for GSK India's new avatar. The British multinational is revamping its business model in India and donning a new approach to create, deliver and capture value via a "one team" effort as it striv...

Matching PubMed Articles

Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis.

India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India's phar...

Inexpensive rotavirus vaccine launched in India.

Yes, India has done it: Decriminalization of suicide in India.

Teaching bioethics in India.

Social Costs of Iron Deficiency Anemia in 6-59-Month-Old Children in India.

Inadequate nutrition has a severe impact on health in India. According to the WHO, iron deficiency is the single most important nutritional risk factor in India, accounting for more than 3% of all dis...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement